Primary Effusion Lymphoma (PEL): In 2011, Sommermann et al. described that the treatment of B-NHL cells (including PEL but also DLBCL and lymphoblastoid cell lines) with chemical an NF-κB inhibitor induced cytoprotective autophagy to overcome the GLUT1 transporter sequestration into the cytoplasm and subsequent leading to a defect in glucose uptake and availability. The gene discussed is NFKB1; the disease is lymphoma.